Phyllis Salzman

556 total citations
16 papers, 396 citations indexed

About

Phyllis Salzman is a scholar working on Psychiatry and Mental health, Neurology and Hematology. According to data from OpenAlex, Phyllis Salzman has authored 16 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 4 papers in Neurology and 3 papers in Hematology. Recurrent topics in Phyllis Salzman's work include Schizophrenia research and treatment (4 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Hemophilia Treatment and Research (3 papers). Phyllis Salzman is often cited by papers focused on Schizophrenia research and treatment (4 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Hemophilia Treatment and Research (3 papers). Phyllis Salzman collaborates with scholars based in United States, Denmark and Spain. Phyllis Salzman's co-authors include Robert H. Roth, Victor H. Morgenroth, Seth L. Schulman, Raymond Sanchez, Robert D. McQuade, Margaretta Nyilas, William H. Carson, Pedro Such, William B. White and Joan Amatniek and has published in prestigious journals such as Hypertension, The Journal of Urology and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Phyllis Salzman

16 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phyllis Salzman United States	11	115	80	79	61	58	16	396
Christian Hönemann Germany	14	38 0.3×	142 1.8×	81 1.0×	26 0.4×	80 1.4×	39	528
John McLaren-Howard United Kingdom	6	257 2.2×	129 1.6×	76 1.0×	77 1.3×	53 0.9×	9	448
James Paskavitz United States	10	76 0.7×	60 0.8×	28 0.4×	66 1.1×	131 2.3×	19	479
Yoshihiro Tani Japan	13	65 0.6×	155 1.9×	127 1.6×	40 0.7×	46 0.8×	33	540
Berrin Aktekin Türkiye	10	125 1.1×	53 0.7×	55 0.7×	17 0.3×	72 1.2×	20	333
Bo Gui China	13	55 0.5×	127 1.6×	46 0.6×	24 0.4×	44 0.8×	32	538
Ana Fernández‐Rodríguez Spain	10	120 1.0×	214 2.7×	13 0.2×	23 0.4×	61 1.1×	15	669
Mansi Shah United States	11	79 0.7×	128 1.6×	165 2.1×	44 0.7×	59 1.0×	13	461
G Testa Italy	10	143 1.2×	102 1.3×	201 2.5×	47 0.8×	20 0.3×	27	365
P. R. Saxena Netherlands	11	87 0.8×	82 1.0×	73 0.9×	16 0.3×	127 2.2×	16	338

Countries citing papers authored by Phyllis Salzman

Since Specialization

Citations

This map shows the geographic impact of Phyllis Salzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllis Salzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllis Salzman more than expected).

Fields of papers citing papers by Phyllis Salzman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phyllis Salzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllis Salzman. The network helps show where Phyllis Salzman may publish in the future.

Co-authorship network of co-authors of Phyllis Salzman

This figure shows the co-authorship network connecting the top 25 collaborators of Phyllis Salzman. A scholar is included among the top collaborators of Phyllis Salzman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phyllis Salzman. Phyllis Salzman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Salzman, Phyllis, et al.. (2017). Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole. Neuropsychiatric Disease and Treatment. Volume 13. 1125–1129. 11 indexed citations

Calabrese, Joseph R., Raymond Sanchez, Na Jin, et al.. (2017). Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder. The Journal of Clinical Psychiatry. 78(3). 324–331. 72 indexed citations

Correll, Christoph U., Eva Kohegyi, Cathy Zhao, et al.. (2017). Oral Aripiprazole as Maintenance Treatment in Adolescent Schizophrenia: Results From a 52-Week, Randomized, Placebo-Controlled Withdrawal Study. Journal of the American Academy of Child & Adolescent Psychiatry. 56(9). 784–792. 20 indexed citations

Peters-Strickland, Timothy, Cathy Zhao, Pamela Perry, et al.. (2016). Effects of aripiprazole once-monthly on symptoms of schizophrenia in patients switched from oral antipsychotics. CNS Spectrums. 21(6). 460–465. 7 indexed citations

Seeberger, Lauren, et al.. (2011). Rasagiline. The Neurologist. 17(6). 318–324. 7 indexed citations

White, William B., Phyllis Salzman, & Steven R. Schwid. (2008). Transtelephonic Home Blood Pressure to Assess the Monoamine Oxidase-B Inhibitor Rasagiline in Parkinson Disease. Hypertension. 52(3). 587–593. 17 indexed citations

Blindauer, Karen, Ira Shoulson, David Oakes, et al.. (2006). A Randomized Controlled Trial of Etilevodopa in Patients With Parkinson Disease Who Have Motor Fluctuations. Archives of Neurology. 63(2). 210–210. 22 indexed citations

Salzman, Phyllis, et al.. (2001). The Rilutek ® (riluzole) Global Early Access Programme: An open-label safety evaluation in the treatment of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 2(3). 153–158. 18 indexed citations

Schulman, Seth L., et al.. (2001). THE EFFICACY AND SAFETY OF ORAL DESMOPRESSIN IN CHILDREN WITH PRIMARY NOCTURNAL ENURESIS. The Journal of Urology. 166(6). 2427–2431. 38 indexed citations

10.

Schulman, Seth L., et al.. (2001). THE EFFICACY AND SAFETY OF ORAL DESMOPRESSIN IN CHILDREN WITH PRIMARY NOCTURNAL ENURESIS. The Journal of Urology. 2427–2431. 2 indexed citations

11.

Ansell, Jack, Robert Lew, Steven P. Ball, et al.. (1992). Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations?. Journal of Thoracic and Cardiovascular Surgery. 104(1). 117–123. 37 indexed citations

12.

Kasper, Carol K., Hugh C. Kim, Edward D. Gomperts, et al.. (1991). In Vivo Recovery and Survival of Monoclonal-Antibody-Purified Factor VIII Concentrates. Thrombosis and Haemostasis. 66(6). 730–733. 14 indexed citations

13.

Davis, Hugh M., et al.. (1990). Lack of Immune Response to Mouse IgG in Hemophilia A Patients Treated Chronically with Monoclate®, a Monoclonal Antibody Affinity Purified Factor VIII Preparation. Thrombosis and Haemostasis. 63(3). 386–391. 4 indexed citations

14.

Davis, Hugh M., et al.. (1990). Lack of immune response to mouse IgG in hemophilia A patients treated chronically with Monoclate, a monoclonal antibody affinity purified factor VIII preparation.. PubMed. 63(3). 386–91. 4 indexed citations

15.

Roth, Robert H., Victor H. Morgenroth, & Phyllis Salzman. (1975). Tyrosine hydroxylase: Allosteric activation induced by stimulation of central noradrenergic neurons. Naunyn-Schmiedeberg s Archives of Pharmacology. 289(4). 327–343. 69 indexed citations

16.

Roth, Robert H., Phyllis Salzman, & Victor H. Morgenroth. (1974). Noradrenergic neurons: Allosteric activation of hippocampal tyrosine hydroxylase by stimulation of the locus coeruleus. Biochemical Pharmacology. 23(19). 2779–2784. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact